Objective Previous studies have reported different opinions regarding the association
between abdominal obesity and diabetic retinopathy (DR) in patients with diabetes mellitus …

Obesity and Type 2 Diabetes (T2D) are two highly prevalent diseases that exhibit a complex
interplay between them. Obesity serves as a primary risk factor for the development of T2D …

Background and aims Controversy remains regarding the prediction effects of different
adiposity measure indicators for the risk of cardiovascular disease (CVD). Our study aimed …

Background Since the triglyceride glucose (TyG) index can reflect insulin resistance, it has
been proven to be an efficient predictor of glycolipid-metabolism-related diseases …

Aims To evaluate the longitudinal association of remnant cholesterol with the incidence of
diabetic nephropathy using a Chinese diabetes cohort. Methods We included 4237 …

Background It is well established that obesity is associated with the risk of heart failure (HF).
However, the data about relationship between visceral fat and the risk of HF are limited …

Background/Aims. Diabetic nephropathy (DN) remained the leading driver of global end‐
stage renal disease (ESRD) incidence, and tens of thousands of studies to date have …

Purpose To evaluate in men with type 2 diabetes the association of cardiometabolic indices
[Visceral Adiposity Index (VAI), Triglyceride Glucose Index (TyG), and lipid accumulation …

Background The differences in fat deposition sites exhibit varying degrees of systemic
inflammatory responses and organ damage, especially in obese individuals with excessive …

Background: Visceral adipose tissue plays an active role in the pathogenesis of type 2
diabetes and vascular dysfunction. The lipid accumulation product (LAP), visceral adiposity …